The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease Francisco Barrera; Javier Uribe; Nixa Olvares; Paula Huerta; Daniel Cabrera; Manuel Romero-Gómez;

Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease Chenyang Mu; Sijie Wang; Zenghan Wang; Jian Tan; Haozan Yin; Yuefan Wang; Zhihui Dai; Dongyang Ding; Fu Yang;

What do we know about nutrient-based strategies targeting molecular mechanisms associated with obesity-related fatty liver disease? Ingrid Rivera-Iñiguez; Arturo Panduro; Sonia Roman; Karina González-Aldaco;